Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal hormonal therapy for advanced prostatic carcinoma.

S Goktas1, E D Crawford

  • 1Division of Urology, University of Colorado Health Science Center, Denver 80262, USA.

Seminars in Oncology
|December 22, 1999
PubMed
Summary

Hormonal therapy is key for advanced prostate cancer, but optimal treatment remains unclear. This review explores current challenges in managing advanced prostate cancer with hormonal therapy, considering survival, quality of life, and costs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics.

Nature communications·2022
Same author

Assessment of knowledge of metabolic syndrome and health literacy level among adults in Western Turkey.

Nigerian journal of clinical practice·2021
Same author

Corroborating evidence refutes batch effect as explanation for fetal bacteria.

Microbiome·2021
Same author

Viable bacterial colonization is highly limited in the human intestine in utero.

Nature medicine·2020
Same author

Results of Real-time Multiplex Polymerase Chain Reaction Assay in Renal Transplant Recipients With Sterile Pyuria.

Transplantation proceedings·2017
Same author

Acute West Nile Virus Meningoencephalitis Diagnosed Via Metagenomic Deep Sequencing of Cerebrospinal Fluid in a Renal Transplant Patient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Area of Science:

  • Oncology
  • Urology

Background:

  • Clinical presentation of stage D2 (M+) prostate cancer is decreasing due to screening.
  • A new spectrum of advanced prostate cancer is emerging.
  • Over half of diagnosed prostate cancer patients may be candidates for hormonal therapy.

Purpose of the Study:

  • To discuss current challenges in the hormonal management of advanced prostate cancer.
  • To address the enigma of optimal hormonal therapy for advanced prostate cancer.
  • To consider factors influencing hormonal therapy choices, including survival, quality of life, cost, and toxicity.

Main Methods:

  • This is a review article.
  • Discussion of current challenges in hormonal management.
  • Exploration of optimal treatment modalities for advanced prostate cancer.

Related Experiment Videos

Main Results:

  • Hormonal therapy has been the primary treatment for advanced prostate cancer for over 50 years.
  • The optimal form of hormonal therapy is not yet definitively established.
  • Several key questions remain regarding the best treatment approaches.

Conclusions:

  • Optimal hormonal therapy for advanced prostate cancer requires balancing efficacy with patient-centered outcomes.
  • Further research is needed to address the complexities of hormonal management.
  • The evolving landscape of advanced prostate cancer necessitates a re-evaluation of treatment strategies.